1·In a test of 66 patients with the blood disease multiple myeloma, a full 100 percent of the subjects saw their cancer reduced by half.
66名患有多发性骨髓瘤(一种血液系统疾病)的患者参与了此项药物试验，结果所有患者的癌灶都缩减了一半。
2·Research funded by the multiple myeloma Re — search Foundation at a small biotech led to a promising new drug for multiple myeloma, a cancer of plasma cells in bones.
Multiple Myeloma研究基金会资助了一家小型生物科技企业的研究，发现了一种很有前途的新药，能够治疗多发性骨髓瘤，一种骨头中原生质细胞的癌症。
3·Multiple myeloma is a cancer of blood plasma cells.
多发性骨髓瘤是一种血浆细胞癌症。
4·Q: When you first developed symptoms of multiple myeloma, you were disappointed to find that available research was not very helpful in deciding what to do.
问：当你最早发现自己出现多发性骨髓瘤症状时，却失望地发现现有研究对如何治疗的决定并无多大帮助。
5·The researchers deployed a combination of peptides—small pieces of protein—that are known to be specific to multiple myeloma cells and are important for their survival.
这些研究人员将肽（蛋白质片段）化合物作为研究重点，该化合物为多发性骨髓瘤细胞所独有，对于这种细胞的生存至关重要。